A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Ancient viral DNA embedded in the human genome has been linked to the genetic risks of certain neurodegenerative diseases, ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

The FDA grants breakthrough therapy designation to expedite ... and there remains a significant unmet need for MS treatment. Year to date, shares of Sanofi have declined 5.5% against the industry ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS).

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a promising breakthrough in the <a ...

People with multiple sclerosis (MS) in Australia have been given hope, after doctors in Britain discovered a possible breakthrough treatment for the condition. Treatments normally used for cancer ...

and there remains a significant unmet need for MS treatment. Year to date, shares of Sanofi have declined 5.5% against the industry’s increase of 7.4%. The FDA’s Breakthrough Therapy ...